home All News open_in_new Full Article

Joaquín Duato, CEO de Johnson & Johnson: "La IA va a acelerar el desarrollo clínico y las compañías, los hospitales y la sociedad se van a beneficiar de ello"

Desde el otro lado del Atlántico, el directivo de origen valenciano pone deberes para que el viejo continente recupere competitividad. Al tiempo que señala las oportunidades de la IA en el desarrollo clínico Leer


today 51 h. ago attach_file Science

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1847467639
Add Watch Country

arrow_drop_down